# China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project

> **NCT05316805** · — · RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 100000 (estimated)

## Conditions studied

- Atopic Dermatitis Eczema
- Prurigo Nodularis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05316805
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-08-31
- **Primary completion:** 2031-12-31
- **Final completion:** 2031-12-31
- **Target enrollment:** 100000 (ESTIMATED)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05316805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05316805, "China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05316805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*